Tech Company Financing Transactions

VentureMed Group Funding Round

On 8/16/2017, VentureMed Group raised $15 million in Series B financing from Endeavour Vision and RiverVest Venture Partners.

Transaction Overview

Company Name
VentureMed Group
Announced On
8/16/2017
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors

Endeavour Vision (Lead Investor) (Alexander Schmitz)

RiverVest Venture Partners (Karen Spilizewski)

Proceeds Purpose
The proceeds from the equity financing will be used to fund VentureMed's strategic clinical plan (which includes current and future trials in the US and Europe) and key operational and research and development programs; expand the company's worldwide commercial team; and support regulatory and reimbursement initiatives for the Company's lead technology platform, FLEX, an innovative, cost-effective device for the endovascular treatment of patients suffering from PAD and arterio-venous access complications.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
2865 N Reynolds Rd. 220A
Toledo, OH 43615
USA
Phone
(567) 661-0768
Website
www.venturemedgroup.com
Email Address
[email protected]
Overview
VentureMed is an innovator in vessel preparation for the interventional treatment of peripheral artery disease (PAD). The company's FLEX Scoring Catheter technologies make vessel preparation simpler, quicker and more cost-effective.
Profile
VentureMed Group LinkedIn Company Profile
Social Media
VentureMed Group Company Twitter Account
Company News
VentureMed Group News
Facebook
VentureMed Group on Facebook
YouTube
VentureMed Group on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Gary Smith
  Gary Smith LinkedIn Profile  Gary Smith Twitter Account  Gary Smith News  Gary Smith on Facebook
Chief Operating Officer
Brent Cousino
  Brent Cousino LinkedIn Profile  Brent Cousino Twitter Account  Brent Cousino News  Brent Cousino on Facebook
Chief Scientific Officer
John Pigott
  John Pigott LinkedIn Profile  John Pigott Twitter Account  John Pigott News  John Pigott on Facebook
VP - Sales
Jeff Tully
  Jeff Tully LinkedIn Profile  Jeff Tully Twitter Account  Jeff Tully News  Jeff Tully on Facebook

 

 

Browse more venture capital transactions:

Prev: 8/16/2017: VividCortex venture capital transaction
Next: 8/16/2017: Molecular Templates venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.